[HTML][HTML] A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes, S Rodriguez-Fernandez… - … , Biology and Medicine, 2023 - Elsevier
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - … , Biology and Medicine, 2023 - hal.univ-smb.fr
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - Nanomedicine …, 2023 - hal.insa-toulouse.fr
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - Nanomedicine …, 2023 - pubmed.ncbi.nlm.nih.gov
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
[引用][C] A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara Fuentes, S Rodríguez Fernández… - 2023 - repositori.udl.cat
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - … Biology and Medicine, 2023 - cnrs.hal.science
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - Nanomedicine …, 2023 - hal.umontpellier.fr
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes… - Nanomedicine …, 2023 - hal-emse.ccsd.cnrs.fr
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
L Almenara-Fuentes, S Rodriguez-Fernandez… - … , Biology and Medicine, 2023 - hal.science
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.
L Almenara-Fuentes… - Nanomedicine …, 2022 - europepmc.org
Autoimmune diseases (AIDs) are caused by the loss of self-tolerance and destruction of
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …
tissues by the host's immune system. Several antigen-specific immunotherapies, focused on …